NCT05911984 2023-06-22
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Unknown
Mabwell (Shanghai) Bioscience Co., Ltd.
Sir Run Run Shaw Hospital
Sir Run Run Shaw Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.